Markus Radsak Selected Research

Markus Radsak Research Topics

4	Neoplasms (Cancer) 01/2022 - 09/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 08/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 10/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021 - 05/2015
2	Inflammation (Inflammations) 10/2017 - 12/2014
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2015 - 08/2011
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 03/2024
1	Systemic Mastocytosis 03/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Anemia 11/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Aspergillosis 01/2022
1	Carcinogenesis 01/2022
1	Leukemia 01/2022
1	Pregnancy Complications 12/2021
1	Thrombosis (Thrombus) 12/2021
1	Febrile Neutropenia 01/2019
1	Sepsis (Septicemia) 01/2019
1	Nausea 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Fever (Fevers) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Cryopyrin-Associated Periodic Syndromes 10/2017
1	Bruton type agammaglobulinemia 10/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2014
1	Skin Diseases (Skin Disease) 12/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2014
1	Hypertension (High Blood Pressure) 12/2014
1	Colitis 10/2012
1	Ulcerative Colitis 10/2012
1	Crohn Disease (Crohn's Disease) 10/2012
1	Hypertrophy 05/2009

3	Antiphospholipid AntibodiesIBA 12/2021 - 08/2011
2	luspaterceptIBA 11/2022 - 10/2017
2	CytokinesIBA 12/2014 - 05/2009
1	Erythropoietin FDA Link 11/2022
1	hydrogen sulfite (bisulfite)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Endothelial Protein C ReceptorIBA 12/2021
1	bis(monoacylglyceryl)phosphateIBA 12/2021
1	Surface Antigens (Surface Antigen)IBA 12/2021
1	quizartinibIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 07/2018
1	Core Binding Factors (Core-Binding Factor)IBA 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	ibrutinibIBA 10/2017
1	InflammasomesIBA 10/2017
1	Immunoglobulin G (IgG)IBA 05/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2015
1	Peroxidase (Myeloperoxidase)IBA 12/2014
1	InterleukinsIBA 12/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014
1	Interleukin-17 (Interleukin 17)IBA 12/2014
1	Messenger RNA (mRNA)IBA 10/2012
1	AutoantigensIBA 09/2010

2	Immunotherapy 01/2022 - 09/2010
1	Cell Transplantation 03/2024
1	Drug Therapy (Chemotherapy) 01/2019
1	Consolidation Chemotherapy 01/2018
1	Therapeutics 10/2017
1	Erythrocyte Transfusion 10/2017